RADIATION-THERAPY FOR RENAL-TRANSPLANT REJECTION REFRACTORY TO PULSE STEROIDS AND OKT3

被引：0
|
作者：
RODRIGUEZ, R
NOYES, W
BELZER, F
KINSELLA, T
机构：
[1] UNIV WISCONSIN HOSP,DEPT SURG,MADISON,WI 53792
[2] UNIV WISCONSIN HOSP,DEPT HUMAN ONCOL,MADISON,WI 53792
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1993年 / 27卷
关键词：
D O I：
10.1016/0360-3016(93)90932-L
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：311 / 312
页数：2
相关论文
共 50 条
  • [21] SELECTIVE OKT3 INDUCTION THERAPY IN ADULT CADAVERIC-DONOR RENAL-TRANSPLANT RECIPIENTS
    THISTLETHWAITE, JR
    HEFFRON, TG
    STUART, JK
    BUCKINGHAM, M
    STUART, FP
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1989, 14 (05) : 28 - 34
  • [22] THERAPY OF REFRACTORY, RECURRENT HEART REJECTION WITH MULTIPLE COURSES OF OKT3
    FRIST, WH
    GERHARDT, EB
    MERRILL, WH
    ATKINSON, JB
    EASTBURN, TE
    STEWART, JR
    HAMMON, JW
    BENDER, HW
    JOURNAL OF HEART TRANSPLANTATION, 1990, 9 (06): : 724 - 726
  • [23] COMPARATIVE-STUDY OF OKT3 AND ANTILYMPHOCYTE-SERUM IN THE PROPHYLACTIC TREATMENT OF RENAL-TRANSPLANT REJECTION IN CHILDREN
    NIAUDET, P
    MURCIA, I
    JEAN, G
    BROYER, M
    ANNALES DE PEDIATRIE, 1990, 37 (02): : 83 - 85
  • [24] MINNESOTA ALG VERSUS OKT3 AS TREATMENT FOR STEROID RESISTANT REJECTION IN RENAL-TRANSPLANT PATIENTS MAINTAINED ON CYCLOSPORINE
    HODGE, E
    NOVICK, A
    LEWIS, R
    STEINMULLER, D
    STREEM, S
    CUNNINGHAM, R
    BAILEY, D
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1986, 8 (06) : A9 - A9
  • [25] CLINICAL AND RENAL HISTOLOGIC PREDICTORS OF RESPONSE TO OKT3 THERAPY USING THE BANFF CLASSIFICATION IN RENAL-TRANSPLANT RECIPIENTS
    KUPIN, W
    VENKAT, KK
    MOZES, M
    ESCOBAR, F
    GOGGINS, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 1019 - 1019
  • [26] RELATIONSHIP OF OKT3 SENSITIZATION AND VASCULAR REJECTION IN CARDIAC TRANSPLANT PATIENTS RECEIVING OKT3 REJECTION PROPHYLAXIS
    HAMMOND, EH
    WITTWER, CT
    GREENWOOD, J
    KNAPE, WA
    YOWELL, RL
    MENLOVE, RL
    CRAVEN, C
    RENLUND, DG
    BRISTOW, MR
    DEWITT, CW
    OCONNELL, JB
    TRANSPLANTATION, 1990, 50 (05) : 776 - 782
  • [27] MORBIDITY OF INTRAOPERATIVE OKT3 ADMINISTRATION IN PRIMARY CADAVERIC RENAL-TRANSPLANT RECIPIENTS
    KUPIN, W
    VENKAT, KK
    IKEMIYASHIRO, D
    OCDOL, H
    MOZES, M
    ANAISE, D
    JOHNSON, C
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (01) : 572 - 574
  • [28] VISUAL-LOSS COMPLICATING OKT3 MONOCLONAL-ANTIBODY THERAPY IN A RENAL-TRANSPLANT RECIPIENT
    JIN, DC
    KIM, SY
    LEE, JM
    KOO, WS
    CHOI, EJ
    YOON, YS
    BANG, BK
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (11) : 2144 - 2146
  • [29] EARLY RECURRENCE OF HEMOLYTIC UREMIC SYNDROME IN A RENAL-TRANSPLANT RECIPIENT DURING PROPHYLACTIC OKT3 THERAPY
    DOUTRELEPONT, JM
    ABRAMOWICZ, D
    FLORQUIN, S
    DEPAUW, L
    GOLDMAN, M
    KINNAERT, P
    VEREERSTRAETEN, P
    TRANSPLANTATION, 1992, 53 (06) : 1378 - 1379
  • [30] THE EFFECT OF INDUCTION ALG (MALG) ON THE OUTCOME OF STEROID-RESISTANT REJECTION TREATED WITH OKT3 IN RENAL-TRANSPLANT PATIENTS
    CHIU, A
    LANDSBERG, D
    CAMERON, EC
    MANSON, ADC
    SHACKLETON, C
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 1039 - 1040
12345